These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 6380394)

  • 21. [Pathophysiology of gallstone formation].
    Wermke W; Borges AC
    Ther Umsch; 1993 Aug; 50(8):541-6. PubMed ID: 8211853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenetic interrelations between cholesterolosis and cholesterol gallstone disease.
    Acalovschi M; Dumitraşcu D; Grigorescu M; Suciu A; Badea G; Paraian I
    Med Interne; 1983; 21(3):175-9. PubMed ID: 6665490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in biliary lithogenicity caused by 4 weeks' weight reduction].
    Janowitz P; Swobodnik W; Wechsler JG; Kuhn K; Wenzel H; Wenk H; Ditschuneit H
    Leber Magen Darm; 1989 Jul; 19(4):190-5. PubMed ID: 2796564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissolution of cholesterol gallstones in mice by the oral administration of a fatty acid bile acid conjugate.
    Gilat T; Leikin-Frenkel A; Goldiner I; Halpern Z; Konikoff FM
    Hepatology; 2002 Mar; 35(3):597-600. PubMed ID: 11870372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on the pathogenesis and treatment of cholesterol gallstones.
    Portincasa P; van de Meeberg P; van Erpecum KJ; Palasciano G; VanBerge-Henegouwen GP
    Scand J Gastroenterol Suppl; 1997; 223():60-9. PubMed ID: 9200309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cholesterol gallstone pathogenesis].
    Méndez N; Uribe M; Jessurun J; Uscanga L
    Rev Invest Clin; 1990 Jul; 42 Suppl():53-7. PubMed ID: 19256135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol enhances membrane-damaging properties of model bile by increasing the intervesicular-intermixed micellar concentration of hydrophobic bile salts.
    Narain PK; DeMaria EJ; Heuman DM
    J Surg Res; 1999 Jun; 84(1):112-9. PubMed ID: 10334899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mechanism of increased gallstone formation in obese human subjects.
    Mabee TM; Meyer P; DenBesten L; Mason EE
    Surgery; 1976 Apr; 79(4):460-8. PubMed ID: 1257908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of hepatic bile composition in gallstone formation in baboons.
    McSherry CK; Morrissey KP; Javitt NB; Glenn F
    Ann Surg; 1973 Nov; 178(5):669-75. PubMed ID: 4355958
    [No Abstract]   [Full Text] [Related]  

  • 31. Biliary excretion of bile acids, lecithin, and cholesterol in hamsters with gallstones.
    Wheeler HO
    Gastroenterology; 1973 Jul; 65(1):92-103. PubMed ID: 4720825
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathophysiology of cholesterol gallstone disease.
    Méndez-Sánchez N; Cárdenas-Vázquez R; Ponciano-Rodríguez G; Uribe M
    Arch Med Res; 1996; 27(4):433-41. PubMed ID: 8987174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The formation of abnormal bile and cholesterol gallstones from dietary cholesterol in the prairie dog.
    Brenneman DE; Connor WE; Forker EL; DenBesten L
    J Clin Invest; 1972 Jun; 51(6):1495-503. PubMed ID: 5063380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of patients with gallstones by lecithin.
    Tuzhilin SA; Dreiling DA; Narodetskaja RV; Lukash LK
    Am J Gastroenterol; 1976 Mar; 65(3):231-5. PubMed ID: 937323
    [No Abstract]   [Full Text] [Related]  

  • 35. Gallbladder mucin, arachidonic acid, and bile lipids in patients who develop gallstones during weight reduction.
    Shiffman ML; Shamburek RD; Schwartz CC; Sugerman HJ; Kellum JM; Moore EW
    Gastroenterology; 1993 Oct; 105(4):1200-8. PubMed ID: 8405867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biliary lipid composition in normalipidemic and prebeta hyperlipoproteinemic gallstone patients. Influence of sucrose feeding of the patients on the biliary lipid composition.
    Cahlin E; Jönsson J; Nilsson S; Scherstén T
    Scand J Gastroenterol; 1973; 8(5):449-56. PubMed ID: 4356589
    [No Abstract]   [Full Text] [Related]  

  • 37. Determination of gallbladder bile lithogenicity in patients with primary biliary cirrhosis.
    Fracchia M; Jazrawi RP; Galatola G
    Ital J Gastroenterol; 1996 Jun; 28(5):255-60. PubMed ID: 8842843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gallstone formation and dissolution.
    Morrissey KP
    Major Probl Clin Surg; 1982; 16():61-100. PubMed ID: 7054618
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of apolipoprotein E polymorphism on bile lipid composition and the formation of cholesterol gallstone.
    Hasegawa K; Terada S; Kubota K; Itakura H; Imamura H; Ohnishi S; Aoki T; Ijichi M; Saiura A; Makuuchi M
    Am J Gastroenterol; 2003 Jul; 98(7):1605-9. PubMed ID: 12873586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered gallbladder bile acidification with long-term total parenteral nutrition.
    Dawes LG; Greiner M; Joehl RJ
    J Surg Res; 1999 Jan; 81(1):21-6. PubMed ID: 9889052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.